JP Stock MarketDetailed Quotes

2395 Shin Nippon Biomedical Laboratories

Watchlist
  • 1354
  • -57-4.04%
20min DelayMarket Closed Jul 5 15:00 JST
56.37BMarket Cap10.19P/E (Static)

Shin Nippon Biomedical Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Shin Nippon Biomedical Laboratories Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 8, 2024

Revenue(YoY)

8.47B

-2.91%
EPS(YoY)

41.71

+1.66%
Analyst Rating

Hold

Jul 4, 2024

Shin Nippon Biomedical Laboratories Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 7.155B--
--2025/Q1-- / 6.705B--
May 8, 20242024/Q48.466B / 8.205B--
Feb 2, 20242024/Q36.100B / 8.416B--
Nov 7, 20232024/Q26.079B / 7.195B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 7.155B--
--2025/Q1-- / 6.705B--
May 8, 20242024/Q48.466B / 8.205B--
Feb 2, 20242024/Q36.100B / 8.416B--
Nov 7, 20232024/Q26.079B / 7.195B--

Unlock Free Earnings Estimates

Shin Nippon Biomedical Laboratories Earnings Reports

  • Shin Nippon Biomedical Laboratories: Extraordinary Report

    Jun 25 22:52 ET

  • Shin Nippon Biomedical Laboratories: Confirmation letter

    Jun 25 01:06 ET

  • Shin Nippon Biomedical Laboratories: Financial Report - 51st Term (2023/04/01 - 2024/03/31)

    Jun 25 00:38 ET

  • Shin Nippon Biomedical Laboratories: Notice Concerning Dividends from Surplus Funds (Year-end Dividend)

    May 23 22:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 4, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      0.00%

    • Hold

      100.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg